Accurate Identification of Melanoma Tumor Margins
REGISTER
The information on this site is not intended or implied to be a substitute for professional medical advice, diagnosis or treatment. Content within the patient forum is user-generated and has not been reviewed by medical professionals. Other sections of the Melanoma Research Foundation website include information that has been reviewed by medical professionals as appropriate. All medical decisions should be made in consultation with your doctor or other qualified medical professional.

Accurate Identification of Melanoma Tumor Margins

› Forums › Cutaneous Melanoma Community › Accurate Identification of Melanoma Tumor Margins

  • This topic is empty.
  • Post
    • December 1, 2012 at 12:42 am
    Gene_S
    Participant

       

      Note that you will have to sign up for a free membership from Medscape to read the following information:

       

      Note that you will have to sign up for a free membership from Medscape to read the following information:

       

      Here are the newly published articles in your area(s) of interest for November 30, 2012:


      Skin Cancer

      Accurate Identification of Melanoma Tumor Margins

       

      Abstract and Introduction

      Abstract

      More than 8000 people die of melanoma in the USA annually. Although early detection of melanoma results in a 5-year survival of up to 90–95%, those presenting at advanced stages have dismal prognoses due to ineffective systemic therapies. In general, patients with early melanoma can be successfully treated with local surgery. However, approximately 8–20% of lentigo maligna melanomas recur, leading to frequent re-excisions, cosmetic issues and, as a result, increased medical costs. An accurate evaluation of melanoma margins is important to prevent local tumor recurrence and progression to advanced stage disease. This review will discuss the role of clinically based noninvasive tools, histology, immunohistochemistry and molecular technologies in melanoma margin assessment. 

       

      https://login.medscape.com/login/sso/logout?notyou=yes&cid=med&urlCache=aHR0cDovL3d3dy5tZWRzY2FwZS5vcmcvdmlld2FydGljbGUvNzcyODAzP3NyYz1ubF90b3BpYw==

    Tagged: 

    • You must be logged in to reply to this topic.
    About the MRF Patient Forum

    The MRF Patient Forum is the oldest and largest online community of people affected by melanoma. It is designed to provide peer support and information to caregivers, patients, family and friends. There is no better place to discuss different parts of your journey with this cancer and find the friends and support resources to make that journey more bearable.

    The information on the forum is open and accessible to everyone. To add a new topic or to post a reply, you must be a registered user. Please note that you will be able to post both topics and replies anonymously even though you are logged in. All posts must abide by MRF posting policies.